Budgetary impact analysis of reimbursement varenicline for the smoking-cessation treatment in patients with cardiovascular diseases, chronic obstructive pulmonary disease or type-2 diabetes mellitus: a national health system perspective

Saved in:

Cedillo, S., et al., Budgetary impact analysis of reimbursement varenicline for the smoking-cessation treatment in patients with cardiovascular diseases, chronic obstructive pulmonary disease or type-2 diabetes mellitus: a national health system perspective. European Addiction Research, vol. 23, n. 1, 2017, p. 7-18.

Ref. 522200

Location: SIIS R.1142

Solicitar documento

Palabras clave:
Drogodependencias, Tabaquismo, Discapacidad, Enfermos, Cardiopatías, Diabetes, Enfermedades respiratorias, Enfermedades crónicas, Tratamiento médico, Fármacos, Efectos, Resultados, Literatura científica, Análisis coste eficacia, Calidad de la atención, Evaluación de servicios, España

Similar Items: Budgetary impact analysis of reimbursement varenicline for the smoking-cessation treatment in patients with cardiovascular diseases, chronic obstructive pulmonary disease or type-2 diabetes mellitus: a national health system perspective